Gotham Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,074
| Closed | -$804K | – | 1569 |
|
|
2024
Q4 | $804K | Sell |
28,074
-24,032
| -46% | -$689K | 0.01% | 980 |
|
|
2024
Q3 | $2.01M | Sell |
52,106
-9,311
| -15% | -$360K | 0.02% | 723 |
|
|
2024
Q2 | $1.98M | Buy |
61,417
+8,995
| +17% | +$290K | 0.03% | 685 |
|
|
2024
Q1 | $2.04M | Buy |
52,422
+7,560
| +17% | +$293K | 0.03% | 644 |
|
|
2023
Q4 | $1.38M | Buy |
44,862
+1,899
| +4% | +$58.5K | 0.03% | 702 |
|
|
2023
Q3 | $960K | Buy |
42,963
+10,489
| +32% | +$234K | 0.02% | 794 |
|
|
2023
Q2 | $698K | Buy |
32,474
+18,992
| +141% | +$408K | 0.02% | 873 |
|
|
2023
Q1 | $323K | Buy |
+13,482
| New | +$323K | 0.01% | 1107 |
|
|
2021
Q3 | – | Sell |
-11,348
| Closed | -$268K | – | 1043 |
|
|
2021
Q2 | $268K | Buy |
+11,348
| New | +$268K | 0.01% | 876 |
|